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Abstract 
The purpose of this project was to evaluate the effectiveness of an educational lifestyle 
modification (LM) intervention on blood pressure (BP) among adults with prehypertension.  
Prehypertension is a precursor to hypertension (HTN) and is a public epidemic in the United 
States. Approximately 68 million (31%) U.S. adult’s aged ≥18 years have hypertension. 
Hypertension can cause significant target organ damage, lead to coronary heart disease, heart 
failure, stroke, and kidney failure. Early identification and the primary treatment of persons with 
prehypertension with LM have the potential to minimize the progression and delay the onset of 
comorbidities associated with hypertension. This quality improvement project retrospectively 
reviewed changes in blood pressure for a small sample (n=5) of patients diagnosed with 
prehypertension who received education about modifying lifestyle behaviors according to 
nationally accepted clinical practice guidelines. Blood pressure measurements were extracted 
from the medical record beginning at the time of the education through a three month period. 
Descriptive data indicates that all five patients had a decrease in systolic and diastolic blood 
pressure. The median systolic blood pressure at baseline was 129 mmHg decreasing to 121 
mmHg at end of study period. The median diastolic blood pressure was 86 mmHg decreasing to 
76 mmHg. Integration of lifestyle modification education and subsequent blood pressure 
monitoring during a routine primary care visit is feasible and may help motivate patients to 
implement changes and subsequently reduce blood pressure. Future studies should include 
identifying strategies for improving patient participation. 
 
  
Chapter One: Introduction 
Prehypertension (preHTN), if untreated, can progress to hypertension (HTN), which is a 
significant risk factor for cardiovascular disease (CVD). Lifestyle modification (LM) such as 
changes in diet, physical activity, and weight loss is the recommended treatment to lower blood 
pressure (BP). Chapter one will discuss the clinical problem of HTN and preHTN, present an 
abbreviated literature review of the affect of lifestyle modification on blood pressure, and 
describe the clinical practice guidelines for primary care treatment. The purpose of this quality 
improvement project, the study questions, and definition of terms are also discussed.  
Hypertension & PreHypertension 
Hypertension, a precursor to cardiovascular disease, is defined as the force of blood 
pushing against the walls of the arteries as the heart pumps blood. HTN can cause significant 
target organ damage. It can lead to coronary heart disease, heart failure, stroke, kidney failure, 
and other health problems. The prevalence of HTN tends to be higher in the fifth and sixth 
decade of life in men and higher in Non-Hispanic blacks or African American populations 
(Buttaro, Trybulski, Bailey, & Sandberg-Cook, 2008). In the U.S., HTN is responsible for one 
out of every seven deaths annually, has no signs or symptoms, and is known as the silent killer 
(NHLBI, 2012). HTN contributes to nearly half of all cardiovascular disease-related deaths in the 
United States (MMWR, 2011). Approximately 68 million (31%) U.S. adult’s aged ≥18 years 
have HTN. Of these, 48 million (70%) were receiving pharmacologic treatment and 31 million 
(46%) had their condition controlled. Control prevalence is low among young adults (31%) and 
Mexican Americans (37%). Prevention and treatment guidelines are available to guide both 
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providers and their patients but patients sometimes fail to adhere to provider recommended 
lifestyle modifications. As a result, risk factors for CVD, kidney disease, and hypertension are 
increased (Svetky et al., 2009).  
Slightly elevated blood pressure is known as preHTN representing a systolic blood 
pressure of 120-139 mmHg and/or diastolic blood pressure of 80-89 mmHg (USDHHS, 2004). A 
population-based survey reported that approximately one-third the US adult population has 
preHTN, a risk factor for HTN and eventual CVD (Gadddam, Ventura, & Lavie 2012). The 
National Health and Nutrition Examination Survey (NHANES) 1999-2000 data showed that 
64% of individuals with preHTN had at least one other cardiovascular risk factor and the 
percentage increased to 94% in those aged 60 years or older (Zhang & Li, 2011). A 10-year 
cumulative incidence of CVD in persons between 35 and 64 years of age who had high normal 
BP was 4% women and 8% men; in older adults 65-90 the incidence was 18% women and 25% 
for men. Persons with preHTN can benefit with reduction in BP, blood glucose, lipid levels, 
weight loss, stress, healthy diet, increased physical activity, and smoking cessation. These risk 
factors for CVD also affect overall health status, health care use, and costs of health care.  
The economic burden of HTN was estimated at $76.7 billion in 2010 (Brill, 2011). A 
randomized study by Milani and Lavie (2009), and a cross-sectional study conducted by 
Mendez-Hernandez et al. (2012), both concluded that wellness intervention and physical activity 
had a considerable effect on lowering health care costs. In any case, preventing the progression 
of preHTN to HTN is an important individual patient and health care system goal.  
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Clinical Practice Guideline JNC7 
The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure, commonly referred to as the JNC7, is the 
evidenced-based clinical practice guideline for the prevention and management of HTN 
(USDHHS, 2004). Originally published in 1976, the JNC7 guideline has been revised seven 
times with the eighth revision in development. The new classification for preHTN is contained in 
the JNC7 along with recommendations for treatment through lifestyle modification and 
pharmacotherapeutics.  
Prehypertension Classification 
 The increased risk that HTN poses related to cardiovascular disease is the reason for the 
revised blood pressure classifications. HTN is classified as a systolic blood pressure (SBP) ≥ 140 
mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg. PreHTN is classified as a SBP 120-139 
mmHg and/or DBP 80-89 mmHg. Furthermore, the measures classifying HTN among persons 
with diabetes have been lowered to <130/80 mmHg. Table 1 compares the blood pressure 
classifications between the JNC6 and the JNC7.  
Table 1 
Comparison of Blood Pressure Classifications, JNC-6 & JNC-7  
JNC- 6 Classification Blood Pressure Measures 
Systolic/diastolic 
JNC 7 Classification 
Optimal <120/80 Normal 
Normal 120-129 / 80-84 Prehypertension 
Borderline 130-139 / 85-89 Prehypertension 
Hypertension 
Stage 1 
Stage 2 
Stage 3 
≥140/90 
140-159 / 90-99 
160-179 / 100-109 
≥180 / 110 
Hypertension 
Stage 1 
Stage 2 
Stage 2 
 
Source: (USDHHS, 2004, p. 11) 
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PreHTN is not designated as a disease category or a diagnosis; rather it is designed to 
identify those individuals at risk of developing HTN. The United States Department of Health 
and Human Services (USDHHS, 2004) based changes on new data on the lifetime risk of HTN 
and the increased risk of cardiovascular complications associated with BP levels that were 
previously considered normal. Reducing blood pressure through lifestyle modifications reduces 
the rate of progression to HTN with age and may prevent HTN altogether. Therefore patients 
should make lifestyle adjustments; and providers need to be more vigilant in monitoring, 
counseling, and adjusting their management of blood pressure, recognizing preHTN.  
Lifestyle Modification Treatment 
Lifestyle modifications (LM’s) treatment regimen is presented in Table 2. LM’s consist 
of weight reduction, Dietary Approach to Stop Hypertension (DASH) diet, dietary sodium 
reduction, increase in physical activity, moderation of alcohol consumption, and cessation of 
tobacco use. These strategies have been found to reduce systolic blood pressure.  
Weight reduction relies on a combination of physical activity and dietary modifications. 
Replacing sweets with fruits and vegetables can reduce calories thus helping to reach weight loss 
goals. The DASH diet is rich in fruits, vegetables, whole-grain, high fiber foods, fat-free, and 
low-fat dairy products, beans, nuts, skinless poultry and lean meats as well as fish containing 
omega 3 fatty acids. Reducing dietary sodium to no more than 2.4 grams (1 teaspoon) of sodium 
a day and adhering to the DASH diet has been shown to reduce systolic blood pressure (Sacks et 
al., 2001; Vollmer, Stevens, Svetkey, Lien, & Champagne, 2008).  
Several organizations recommend at least 30 minutes of regular aerobic physical activity 
most days of the week (USDHHS, 2004; The American Diabetes Association, 2012; & 
American Heart Association, 2012). Physical activity reduces systolic blood pressure by 4-9 
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mmHg (USDHHS, 2004). Physical activity can include walking, aerobic exercise, swimming, 
dancing, using stairs, and flexibility exercises. Losing weight may require more than 30 minutes 
a day. Benefits of physical activity reach further than reduction in BP; it reduces stress, 
strengthens the heart and lowers risk for pre-diabetes, heart disease and stroke. Increasing the 
awareness of the long-term benefits of lifestyle changes can have a positive long lasting effect on 
BP without the use of drugs.   
Table 2  
Lifestyle Modifications to Manage Hypertension 
Modification 
 
Recommendation Approximate Systolic Blood 
Pressure Reduction (Range) 
 
Weight reduction Maintain normal body weight  
(body mass index 18.5–24.9 kg/m2) 
 
5–20 mmHg/10 kg weight loss 
 
Adopt DASH 
eating plan 
Consume a diet rich in fruits, vegetables, 
and low fat dairy products with a reduced 
content of saturated and total fat. 
 
8–14 mmHg 
Dietary sodium 
reduction 
Reduce dietary sodium intake to no more 
than 100 mmol per day 
(2.4 g sodium or 6 g sodium chloride). 
 
2-8 mmHg 
Physical activity  
 
Engage in regular aerobic physical 
activity such as brisk walking 
(at least 30 min per day, most 
days of the week). 
 
4–9 mmHg 
Moderation of 
alcohol 
consumption 
Limit consumption to no more than 2 
drinks (1 oz or 30 mL ethanol; e.g., 24 oz 
beer, 10 oz wine, or 3 oz 80-proof 
whiskey) per day in most men and to no 
more than 1 drink per day in women and 
lighter weight persons. 
 
2–4 mmHg 
 
Source:  (USDHHS, 2004, p. 26) 
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Pharmacotherapeutics 
It is common practice to implement lifestyle modifications before prescribing drug 
therapy (Pettman, Buckley, Misan, Coates & Howe, 2009). Treating preHTN and HTN with 
pharmacotherapeutic therapy usually occurs if LMs have failed. The goal for individuals with 
preHTN, without any co-morbidity is to reduce BP to normal levels, and to 139/89 mmHg or less 
for individuals with HTN. JNC7 (USDHHS, 2004) states that greater emphasis should be placed 
on managing systolic hypertension because of increased cardiovascular and renal disease, and 
stroke, as the population gets older. Drug therapy therefore would consist of one of the several 
different classes of drugs such as diuretics, angiotensin converting enzyme inhibitors, 
angiotensin receptor blockers, beta blockers, and calcium channel blockers. Two or more of 
these antihypertensive may be required to control blood pressure.  
Hypertension Treatment Outcomes 
 Studies cited in the JNC7 (USDHHS, 2004) document that LM treatment produces a 
decrease in BP. Implementing the LM of weight reduction yields a 5-20 mmHg/10kg of weight 
loss. An individual usually achieves weight loss through physical activity and that produces an 
additional 4-9 mmHg decrease in BP. Replacing unhealthy foods with fruits and vegetables 
brings us to the second biggest reduction with the adaption of the DASH diet that yields an 8-14 
mmHg decrease in BP. Dietary sodium restriction and moderate alcohol intake reduces BP by 
approximately 2-8 mmHg. Studies report that implementing more than one LM has a greater 
impact on lowering BP. In 2005 Aldana et al. conducted a study that assessed the impact of 
healthful eating and physical activity after attending a 40-hour educational course. BP improved 
within only six weeks. Consistent with the JNC7 (USDHHS, 2004), a combination of two or 
more lifestyle changes can produce better results.  
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Studies published after the JNC7 (USDHHS, 2004) continue to substantiate the impact of 
LMs on BP. Elmer et al. (2006) concluded that the established recommendations known as LM, 
plus the DASH diet, does lower BP. In 2008 Fleming and Godwin studied the effect of physical 
activity and healthy eating on BP and reported a positive result. Svetkey et al. (2009) conducted 
a study using physicians as control and intervention group as well as the patients in a control and 
intervention group. For the physicians, the interventions were online training modules, 
evaluation and treatment algorithm, and quality improvement procedure that assessed clinical 
performance measures. The interventions for the patients included 20 weekly group sessions. In 
this study the outcome was greatly improved with the combination physician intervention 
combined with patient intervention demonstrating a 9.7 ± 12.7 mmHg decrease in BP. 
Clinical Problem 
Individuals may be unaware that they have preHTN due to the reclassification of 
previously identified “normal” systolic and diastolic blood pressure levels. Consequently, they 
may not realize their risk for developing HTN and the associated risk for poor health outcomes. 
Several patients attending a primary care clinic in rural North Florida have been observed to 
have preHTN. A subsequent record review found that some patients also have additional risk 
factors such as hyperlipidemia, high blood glucose, and/or are overweight.  
Demographic characteristics such as age, minority status, income, education, and rural 
residence may be factors that create barriers to HTN prevention (USDHHS, 2004) Access to 
exercise programs in school, availability of healthy food choices in school, places of work and 
restaurants, coupled with the higher cost of healthy food products is a major barrier. Individuals 
have to overcome barriers such as insufficient exercise facilities and access to food stores. It is 
difficult for individuals to change lifetime habits. Everyday traditions identified to a particular 
 8 
culture, such as high salt diets in the African American and other minority population can be 
considered known barriers to adherence (USDHHS, 2004). Patients living in a rural area that are 
low income, under or non-insured, unemployed, and have limited access to transportation may be 
particularly challenged to adhere to lifestyle modifications. 
According to the evidence, making patients aware of their preHTN and guiding them 
toward making lifestyle modifications should produce a positive result in lowering their BP as 
well as decreasing other CVD risk factors (Johnson et al., 2011). It is essential that Primary Care 
Providers (PCP’s) discuss preHTN with patients and counsel them on lifestyle modifications. 
Primary Care Providers are well suited to educating patients. Finding ways to motivate an 
individual can be done if there is a relationship of trust and respect, which is developed and or 
built during patient visits. Good customer service, access to the provider and decreased waiting 
time, often leads to patient adherence and the desire to engage in their own care (USDHHS, 
2004).  
Whittemore et al. (2010) reported a mixed-method clinical trial implementing a lifestyle 
program to prevent type II diabetes implemented by nurse practitioners (NPs) in their primary 
care facilities. The NPs first completed a questionnaire on confidence of preparedness and 
effectiveness in providing LM education and received a two-hour training session on the 
Diabetes Prevention Program protocol for enhanced standard care sessions and documentation. 
The program provided an adult population at risk for type II diabetes with education, behavioral 
and psychological strategies to promote lifestyle change. The enhanced standard care NP group 
received 1.5 hours of professional support while the lifestyle change NP group received 4.1 
hours of professional support. At the end of the study a survey was sent to participants and a sub-
sample were interviewed to evaluate their satisfaction with the program. Participants reported 
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knowing the NP, wanting more information on healthy eating, concern about risk of type II 
diabetes, and not wanting to take medicine, as motivating factors for change.  
Project Purpose 
The purpose of this quality improvement project was to evaluate outcomes of an 
educational lifestyle modification program delivered to adults with preHTN in a primary care 
rural setting. The study question was:  Among adults with preHTN, does an educational lifestyle 
modification program implemented in a primary care setting lower blood pressure?  
Definition of Terms 
Prehypertension 
Blood pressure ranging from 120-139 mmHg systolic and/or 80-89 mmHg diastolic 
(USDHHS 2004, 7, p. xiv.). 
Hypertension  
The condition in which a person displays a systolic blood pressure of 140 mmHg or 
higher and/or a diastolic blood pressure of 90 mmHg or higher, or is current user of 
antihypertensive medication (Rigsby, 2011, p.1). 
Lifestyle Modification 
Includes weight loss, physical activity, lowering dietary salt intake, smoking cessation, 
reducing stress and lowering alcohol consumption (Ebrahim & Smith, 1998, p. 1). 
Blood Pressure 
That force in arterial structures created by interplay of flow, volume, and constriction 
(Buttarro, et al., 2008, p. 572). 
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Summary 
 PreHTN is an important medical issue. Untreated, it can progress to hypertension, which 
increases risk for morbidity and mortality associated with CVD. The JNC7 (USDHHS, 2004) 
offers treatment approaches including LM and pharmacological therapy. LM interventions such 
as weight loss, DASH diet, physical activity, dietary sodium reduction and reduction in alcohol 
consumption have been shown to lower BP. Individuals with preHTN may not recognize the 
seriousness of this condition and may not be actively engaging in LM that could prevent the 
development of HTN. The classification of preHTN prompts providers and patients to actively 
intervene and prevent the progression to HTN. The purpose of this project is to assist adult 
patients in a primary care setting to lower their BP through LM.  
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Chapter Two:  Review of Literature 
This chapter will describe the search process, assess the JNC7 (USDHHS, 2004), and 
discuss the results of the review of literature. A critical appraisal of the JNC7 (USDHHS, 2004) 
was conducted using the Appraisal of Guidelines for Research and Evaluation II (AGREE) 
instrument (Brouwers et al., 2010). Systematic reviews, meta-analyses, and randomized 
controlled trials (RCTs) focused on effect of lifestyle modification on blood pressure in adults 
with prehypertension were appraised.  
Search Process 
A literature search was conducted using The Cochrane Library, EBSCO Host, CINAHL, 
Science Direct, ProQuest, and Medline databases. Keywords employed in the search were:  
hypertension or prehypertension or blood pressure; and lifestyle modification or behavioral 
modification; and African American, diet, physical activity, weight loss, systematic review, 
meta-analysis, and RCTs. The search focused on studies published since the JNC7 (USDHHS, 
2004) that included publication dates between 1998 and 2012. Inclusion criteria were:  diagnosis 
of hypertension or preHTN, adults aged 18 years of age or older, with lifestyle modification 
treatment. The search revealed 21 research studies of which 13 did not meet inclusion criteria, 
for example, studies of treatment with pharmacologic agents. Eight studies met the inclusion 
criteria and were used in the analysis (Table 3). The strength of the research evidence was 
assessed as well as applicability of methods for primary care practice.  
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Clinical Practice Guideline Evaluation 
The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure, JNC7 (USDHHS, 2004), submitted 
November 2004 to the journal Hypertension is the clinical practice guideline that drives practice 
on hypertension. The JNC7 (USDHHS, 2004) was evaluated using the AGREE II (Brouwers et 
al., 2010) instrument to evaluate the quality and applicability of a guideline. It uses the basis of 
six domains separated into 23 questions to accomplish an evaluation. The six domains consist of: 
scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, 
applicability, and editorial independence.  
Scope and Purpose 
 The rationale and purpose for this guideline is explicitly described in the abstract and 
then again in the introduction. Their purpose was to increase the awareness, prevention, 
treatment, and control of hypertension. In the forward they state that the guidelines are a 
synthesis of scientific evidence and guidance geared to busy PCPs. Many key messages can also 
be found in the abstract. Identified in this guideline are people with HTN and preHTN. It 
identifies treatment with LM, and pharmacotherapy (USDHHS, 2004). 
Stakeholder Involvement 
 The guideline development group dedicated to the management of, and the prevention of 
morbidity and mortality, and the consequences of uncontrolled hypertension include a 
conglomerate of organizations from all relevant groups. The views of the target population were 
sought and the target users are clearly defined. The National Heart, Lung, and Blood Institute 
have administered the National High Blood Pressure Education Coordinating Committee, 
consisting of 39 major professional, public, and voluntary organizations that participated. The 
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federal agencies that also participated were: Agency for Health Care Research and Quality, 
Centers for Medicare & Medicaid Services, Department of Veterans Affairs, Health Resources 
and Services Administration, National Center for Health Statistics, National Heart, Lung, and 
Blood Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases 
(USDHHS, 2004).  
Rigor of Development 
The need to update the guideline was based on the overwhelming publications of new 
hypertension observational studies and clinical trials; the need for new, clear and concise 
guidelines useful to clinicians; the simplification of BP classification; and the need to get 
enhanced public benefit results. Using peer-reviewed, scientific literature that spanned from 
January 1997 through April 2003 they developed two versions. The succinct version was 
launched in May 2003. The more in depth version also offered justification for the committee’s 
recommendation. The committee continued their efforts to stay abreast of the studies being 
conducted on hypertension by investigating on four different levels that cover science; long-
range planning; professional, patient, and public education; and program organization, thus being 
clear and concise in their methods.  
 The guideline outlined the health benefits and the possible consequence for non-
adherence. The committee considered evidence that showed pertinent outcomes of concern to 
patients that was of such magnitude it warranted changes in practice. The studies show an 
unambiguous link between heart disease, stroke, and renal disease to hypertension. Thirty-three 
national hypertension leaders externally reviewed the JNC7 Express and the complete JNC7 
(USDHHS, 2004). 
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Clarity of Presentation 
 The key recommendations from this guideline are descriptive in that it is appropriate for 
the population and situation in which it addresses. It gives a precise definition of prehypertension 
and hypertension and the two stages. The guideline clearly outlines the different classes of 
antihypertensive therapy, combinations, and that it may take two or more to meet goal. They also 
outline the different classes that work better with other co-morbidities such as diabetes and heart 
failure. They include that a combination of LMs such as diet, exercise, weight loss, and physical 
activity enhance the positive affect on BP. 
Applicability 
 The JNC7 (USDHHS, 2004) lists facilitators that assist with the reinforcement of LM and 
BP control. Those facilitators include but are not limited to nurse managers, pharmacists, 
managed care organizations, licensed nutritionists, optometrists and worksite occupational health 
departments. Incorporating a LM and BP regimen should be individualized to the patient and 
include the patient in the decision making process. Recommendations indicate how the 
guidelines can be applied in practice.  
The barriers to guideline application were also identified and solutions to those barriers 
were described. The primary reason for non-adherence to treatment guidelines related to 
medication costs. The patient and primary care provider must agree upon a BP goal, time frame 
of achievement and monitoring frequency. The guideline acknowledges that social services or 
someone to assist individuals with special needs programs and other resources can help with 
adherence (USDHHS, 2004). 
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Editorial Independence 
This guideline provides the parameters for the different levels and stages of hypertension 
including the new category of prehypertension. The recommended approach the guideline 
suggests is appropriate for use in the primary care clinical setting. The National Heart Lung and 
Blood Institute Health Information Center serves the health professional, and the 
recommendations are applicable to patients, and the public as well on things such as prevention, 
diagnosis, and treatment. 
The JNC7 (USDHHS, 2004) has a perfect score in all domains using the AGREE II tool. 
The objectivity of the guideline were clearly written and met, and the overwhelming strength of 
the guideline has clearly been justified. The work was supported entirely by the National Heart 
Lung and Blood Institute. The Executive Committee and team of reviewers, and writers assisted 
as volunteers without remuneration. 
Literature Review 
Systematic Reviews 
 The two systematic reviews conducted by Ebrahim & Smith (1998); and Fleming & 
Godwin (2008) reviewed a total of 40 RCTs. Ebrahim & Smith (1998) presented studies of 33 
RCTs that looked at the effects on systolic BP from different aspects of lifestyle modifications. 
Thirty-two studies included LM’s of weight reduction, salt restriction, stress management and 
exercise. One study included alcohol reduction. All studies were of six months duration or longer 
and reported a reduction of systolic BP in all areas studied with the greatest affect of -5.2 mmHg 
with a 95% CI (-8.3, -2.0) from weight reduction. Ebrahim & Smith (1998) determined that 
although weight reduction and salt restriction seem to have the greatest effect on systolic BP, a 
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larger study is needed, and methodological constraints make it difficult to test LM’s compared to 
pharmacological interventions.  
 Fleming & Godwin (2008), compared studies in primary care, by PCP’s with a control 
group using usual care. They measured cardiovascular risk scores, blood pressure, lipid levels, 
weight or body mass index (BMI), and morbidity and mortality as outcomes. Three of the six 
studies that used BP as an outcome found that there was small but significant benefit to LM 
intervention. Of the seven RCTs compared, four found significant positive effect on the 
outcomes of interest and two found consistent effects across the several outcomes. Although 
statistically significant, and showing that the main effects were on blood pressure and lipid 
levels, they were rather small. The authors concluded that PCP’s time might best be spent 
counseling patients at highest risk of disease given the small improvement in BP among lower 
risk groups.  
Meta-Analyses 
 Two meta-analyses reviewed 51 articles, all of which studied BP and BMI. Some articles 
reviewed waist circumference, dyslipidemia, fasting plasma glucose, and smoking and drinking 
as well. One study by Guo et al. (2011) was conducted after the guideline was released. Between 
all studies a total of 255,615 participants were included. Both analyses conclude that LM has a 
positive effect on decreasing blood pressure.   
Neter, Stam, Kok, Grobbee, & Geleijnse (2003) conducted a meta-analysis reviewing 
studies published on the influence of weight reduction on blood pressure. This meta-analysis 
documents the improvement in BP by the reduction in weight gain in hypertensive patients, 
especially those taking antihypertensive medications. They identified 25 articles that met their 
criteria, especially non-pharmacological weight reduction. Energy or calorie restriction, 
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increased physical activity and sometimes a combination of both were used in the meta-analysis 
of the RCTs. Whelton, Chin, Xin & He (2002), concluded that BP was considerably reduced 
with minimal overall weight loss, implying that exercise alone lowers BP freely of changes in 
body weight.  
In 2011, Guo et al. (2011) reviewed 26 studies of which 20 were cross-sectional and six 
were longitudinal studies with a combined sample size of 250,741 individuals. Their outcome 
measures were the predictors of preHTN; BMI, and waist circumferences, dyslipidemia, fasting 
plasma glucose, smoking and drinking, and predictors of progression from preHTN to HTN 
(increased age, male sex, low education status and C-reactive protein).  
Guo et al. (2011) also found significant association of fasting plasma glucose, total 
cholesterol, and LDL-C with HTN. Eight studies done on fasting plasma glucose were included 
in this meta-analysis. With 10 studies investigating the correlation between smoking and 
drinking eight of which reported drinking met with conflicting results. Although they report their 
limitations as only searching PubMed and The Cochrane Library and admit there needs to be 
further study, both meta-analyses conclude by saying many of the risk factors mentioned 
preclude the progression of preHTN to HTN.  
Randomized Control Trials 
 Four randomized control trials reported on outcomes of blood pressure from any form of 
lifestyle modifications. A total of 2,133 individuals participated in these trials. One study by 
Aldana et al. (2005) also measured knowledge, nutrition, physical activity and other chronic 
disease risk factors. Overall the studies compared usual care or no intervention to at least one 
lifestyle modification. Three of the four studies held an educational intervention course of some 
kind. One study however assigned the control group a typical United States diet and the DASH 
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diet was assigned to the intervention group (Sacks et al., 2001). Another study included the 
physicians as part of the study and used internet-based training, self-monitoring and quarterly 
feedback reports as the intervention (Svetkey et al., 2009). The latter two studies both showed 
significant positive effect of the interventions used. 
 Elmer et al. (2006) is continuation of a prior study at 18 months, however their measured 
outcomes were the individual components of lifestyle modification. They used weight, 
cardiorespiratory fitness, and physical activity assessed at baseline, six months, and 18 months. 
The results after 18 months showed an increase in fitness measured by heart rate for all groups. 
After 18 months, all three groups showed a decrease in absolute blood pressure. Their 
conclusion, individuals with preHTN and stage 1 HTN can implement LM and sustain them for 
an extended period, control their BP, and reduce their risk for CVD. 
After Aldana et al. (2005) conducted the last RCT reviewed, their conclusion support the 
RCTs presented earlier. They used the Coronary Health Improvement Project intervention to 
which is focused on participants’ improvement in cognitive understanding of the importance of a 
healthy lifestyle, improvement in nutrition and physical activity, and improvements in variables 
that affect diabetes, HTN, CVD and cancer. They held a 40-hour educational course delivered 
over a four-week period, meeting four times a week for two hours. The reported dramatic change 
in BP among the participants in the intervention group was that prevalence of HTN decreased 
from 18.5 % to 7.5% at follow up, supporting lifestyle modification.  
Strength of the Evidence 
The purpose of the literature review was to appraise the evidence of the effectiveness of 
an educational intervention of LM changes on BP in adults with preHTN. There is a broad scope 
of evidence that has been steadily and methodically reviewed. The systematic reviews are 
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considered the most rigorous and the strongest level (Level 1) of evidence and approach to 
minimization of bias in summarizing research (Melynk & Fineout-Overholt, 2011). The five 
randomized control trials reviewed are considered to be Level II evidence. They are generated 
from at least one well-designed randomized clinical trial (Melynk & Fineout-Overholt, 2011). 
Conclusion 
This literature review supports that lifestyle modification has a positive effect on 
lowering blood pressure in adults. This suggests that educational intervention creates awareness 
of the many risk factors leading to CVD and that those risk factors can be changed. As shown in 
the study done by Svetkey et al. (2009), primary care providers can also benefit from educational 
intervention. It seems to be the consensus of most of the studies reviewed that some participants 
fail to continue with behavioral changes once the study is completed. It would be ideal to see 
individuals adopt healthy lifestyle behaviors and maintain them for life. Based on the findings in 
this literature review, LM’s should be implemented. Evidence shows that this implementation 
can reduce BP, thereby preventing the progression from preHTN to hypertension. The 
interventions in these studies, some being complex, are applicable to practice. In the primary 
care setting these very same standards of care can be implemented for the type of population that 
is unique to a rural area.  
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Table 3 
Literature Analysis of Lifestyle Modifications Effect on Blood Pressure 
Author 
(Date) 
Design Sample Outcome 
Measures 
Intervention Results Limitations 
Ebrahim & 
Smith 
(1998) 
Level I 
Systematic 
Review 
25 articles- 
from 1966-
1995 
BP Salt restriction, 
weight reduction, 
stress management, 
exercise, & alcohol 
reduction 
Control group: 95% CI: salt restriction -2.9 (-
5.8,0.0); weight loss -5.2(-8.3,-2.0); stress control 
-1.0(-2.3,+0.3); & exercise -0.2(-2.8,+2.4). 
Normotensive: salt restriction -1.3(-2.7,+0.1); 
weight loss -2.8(-3.9,-1.8); exercise -0.2(-
2.8,+2.4), & alcohol reduction -2.1(-4.1,-0.1). 
Weak evidence except for weight loss. 
 
Some low 
methodological 
quality and not 
well controlled.  
Findings may be 
overestimates of 
effect.  
Fleming & 
Goodwin 
(2008) 
Level I 
Systematic 
Review 
7 RCTs BP, lipids, 
BMI, 
cardiovascular 
risk scores, 
Physical activity, 
healthy-eating 
2 studies showed positive results in BP (2 mm 
Hg), as compared to control group with size of 
effects small.  
Meta-analysis not 
possible due to 
non-homogeneity 
of study 
populations.  
 
Guo et al. 
(2011) 
Level I 
Meta-
Analysis 
26 articles; 20 
cross-
sectional; 6 
longitudinal. 
Sample of 
250,741 
individuals 
BMI and waist 
circumference, 
dyslipidemia, 
Fasting Plasma 
Glucose, 
smoking and 
drinking 
None. Assessing 
epidemiology of 
preHTN. 
Overall pooled prevalence-36%; males>females 
at (40% vs 33%). Standardized mean difference 
for BMI was 1.37(95% [CI], 1.20-1.55); total 
cholesterol, 8.08(95% CI, 6.71-9.46) for LDL 
5.14(95% CI, 3.09-7.18); and for FPG, 4.23 (95% 
CI, 3.28-5.18) all showed more significant in 
females. Pooled OR was 1.13 (95% CI, 0.93-
1.37) for smoking; 0.98 (95% CI, 0.69-1.39) for 
drinking. Findings identify modifiable risk factors 
amendable to intervention.  
 
Search databases 
limited to PubMed, 
Cochrane, English 
and Chinese.  
Potential for 
measurement error 
of outcomes.  
Time delay 
between search and 
publication.  
Neter et al. 
(2003) 
Level I 
Meta-
Analysis 
25 RCTs;  
4874 
participants 
BP, BMI N/A Net weight reduction of -5.1kg (95% CI, -4.88—
2.25) by energy restriction, increased physical 
activity or both reduced SBP by -4.44 mmHg 
(95% CI, -5.93—2.95); DBP -3.57 mmHg (95% 
CI, -4.88—2.25); Significantly lower BP 
reductions with avg weight loss >5 kg (-6.63 
mmHg [95% CI, -8.43—4.82] vs -2.70 mmHg 
[95% CI, -4.59—0.81]) and DBP (-5.12 mmHg 
Not specified. 
RCT’s used in 
analyses were 
noted to have high 
internal validity. 
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Author 
(Date) 
Design Sample Outcome 
Measures 
Intervention Results Limitations 
[95% CI, -6.48—3.75] vs -2.01 mmHg [95% CI, 
-3.47—0.54]). Strong evidence for weight loss.  
 
Aldana et 
al. 
(2005) 
Level II 
RCT 
337 
volunteers. 
Age 43-81. 
Change in 
health 
knowledge, 
nutrition, 
physical 
activity, risk 
factors 
including BP 
40-hour 
educational course 
over 4 weeks, 4 
times per week for 
2 hours.. 
Beneficial mean changes in scores tended to be 
significant for the intervention group. Variables 
improved scores: health knowledge, % body fat, 
total steps/week and most nutrition variables. 
Improvement in resting heart rate, total 
cholesterol, LDL cholesterol, and SBP and DBP. 
Control group-small but significant 
improvements in health knowledge, SBP and 
DBP, glucose, and some nutrition variables. 
 
Participants highly 
motivated and had 
higher ed level 
compared to 
community.  
Short intervention 
(4 wks) with short 
follow (6 mos) 
 
Elmer et al. 
(2006) 
Level II 
RCT 
PREMIER 
18 month 
results 
810 adults 
with preHTN 
or stage 1 
HTN 
BP 1.Behavioral 
intervention, 
2.Behavioral plus 
Dash diet 
3.Advise only 
 
Blood pressure decreased in all three groups. 
Reduction was greater for participants in groups 1 
and 2 but not significantly different compared to 
the advice only group. Participants were able to 
sustain lifestyle changes over time. 
Multi-site 
comprehensive 
RCT with 
population 
heterogeneity. 
Volunteers 
randomized.  
Sacks et al. 
(2001) 
Level II 
RCT, 
Multi-site 
 
412 adults 
with BP 
>120/80 
BP 30 day salt 
reduction + DASH 
diet 
DASH diet with low sodium level reduced BP by 
7.1 mmHg (p<0.001) in participants without 
HTN; by 11.5 mmHg (P=0.03) in participants 
with HTN. Combination had greater effect. 
Multi-site trial with 
population 
heterogeneity. 
Volunteer 
randomized.  
Svetkey et 
al. 
(2009) 
Level II 
RCT  
8 primary 
care 
practices; 
32 MD’s, 574 
patients 
Change in SBP 
at 6 months.  
Change in 
DBP at 6 & 18 
months. 
Height, 
weight, intake, 
physical 
activity, 
medications, 
lab measures.  
1. Trained MD 18 
mos. Intervention. 
2. Control MD, 
usual care. 
3.Patient 20 week 
LM group session  
4. Patient control 
usual care advice 
for BP control 
office visit. 
 
MD control + Patient control, blood pressure fell 
by mean 6.7 ± 12.8 mmHg at 6 mos;  
MD intervention + Patient control, blood pressure 
fell by 5.3 ± 12.1 mmHg 
Pt intervention + MD control, blood pressure fell 
by 7.1 ± 12.1 mmHg.  
MD intervention + Patient intervention, blood 
pressure fell by 9.7 ± 12.7 mmHg significant 
compared to other groups, p=.0072 
At 6 months there was a significant interaction 
effect for MD + Patient intervention.  
Patient completion 
at 6 months was 
91% and at 18 
months was 88%.  
Only 10% of 
patients were 
randomized 
therefore not 
generalizable.  
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Chapter Three:  Methods 
 This chapter describes design, source, sample, collection, measures and analysis of the 
data. The design is a retrospective review of existing data obtained from patient records pre and 
post education about lifestyle modification. The answer to the project question, “In adults with 
prehypertension does education on lifestyle modification affect blood pressure,” was explored. 
Procedure, Sample, and Data Collection 
An educational intervention on lifestyle modification for adults with preHTN was 
implemented in a rural primary care practice following recommendations of the JNC7 
(USDHHS, 2004) and approval of the Primary Care Physician of the clinic. The educational 
lifestyle modification program was delivered by the Nurse Practitioner to adult patients 18 years 
of age and older who were identified as being prehypertensive during a non-related scheduled 
office visit beginning in February 2013. For intervention details and script See Appendix A. 
Appendix B includes a color brochure designed and distributed by the NP regarding blood 
pressure and lifestyle modification. A web link to a 1.32-minute educational video was also 
shown during the visit. The LM intervention included counseling related to physical activity, 
weight loss, diet, sodium intake, alcohol intake, and smoking cessation.  
Data collected during the visit per customary clinical practice was BP, height, weight, 
and BMI, and was recorded in the patient electronic health record (EHR). Patients identified as 
prehypertensive were scheduled for free monthly blood pressure checks in the primary care 
office. A medical assistance trained in BP measurement protocols conducted the blood pressure 
follow-up checks. The medical assistant also received 30 minutes of training on how to maintain 
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a separate paper log of patients referred for blood pressure. Following standard practice the 
medical assistant recorded blood pressure, height and weight, and BMI into the electronic health 
record (EHR). Once the quality improvement project was completed the medical assistant was 
instructed on how to extract that information from the EHR, assign a code to the individuals in 
order to de-identify the data and enter it into an Excel spreadsheet. Once verified and analyzed, 
the medical assistant used the office shredder to destroy all project-related documents. 
Measures 
Descriptive Variables 
 Descriptive variables extracted from the EHR on patients who were prehypertensive 
included age in years, gender, as well as clinical measures of BP, height, weight, and BMI. Age 
and gender were used to describe the population sample. Coding of these variables is described 
in Table 4.  
Outcome Variables 
 Blood pressure was the outcome of interest. Actual blood pressure readings were 
extracted from the EHR. The first BP measurement was the baseline and used to compare and 
categorize subsequent measures. A categorical variable indicating decrease in BP was generated 
and coded as yes decrease, no decrease, or no change in BP for subsequent measures. 
Participants who did not return for monitoring were coded as “lost to follow-up” in blood 
pressure.  
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Table 4 
Variables Used for Project and Their Coding 
Descriptive Variables Coding 
Age in years 18-99 
 
Gender 1=male, 2=female 
 
Weight in pounds 00.0-000.0 
 
Decrease in weight No=0, Yes=1, No need=2 
 
Height in inches 00 
 
Body Mass Index (BMI) 00.0 
 
BMI category 1=Underweight = Below 18.5 
2=Normal = 18.5-24.9 
3=Overweight = 25.0-29.9 
4=Obese = 30.0 and above 
 
Improved BMI No=0, Yes=1, No need=2 
 
Outcome Variable  
Blood pressure measured in 
mmHG 
000 systolic 
00-000 diastolic 
 
Decrease in blood pressure No=0, Yes=1, Lost to follow-up=2 
 
 
Data Analysis 
Data was obtained from the EHR and entered into an excel file by the medical assistant. 
A statistician was consulted. The data was analyzed using SPSS® statistical software (Version 
21.0, 2013, Excel, 2010). Categorical variables were described using counts and percentages. 
Continuous variables were described using median, means, standard deviations (SD), and ranges 
(minimum, maximum). The change in systolic and diastolic blood pressure from baseline to end 
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of study was explored using descriptive analysis. Bar charts were used to show relationships 
between variables. 
Feasibility 
 The project was feasible and additional resources were not required. The regular office 
visit was used to implement the project using customarily collected data. The educational 
lifestyle modification program was part of the regular office visit taking less than 20 minutes of 
time. The use of available office supplies such as copy paper and copy machine was used to 
make copies of BP Fact Sheet and DASH diet plan.  
Protection of Human Subjects 
This quality improvement project commenced upon approval from the Institutional 
Review Board (IRB) of the University of North Florida (UNF) and Baptist Medical Center (see 
Appendix C and D). The UNF IRB deemed the project “not research involving human subjects” 
and therefore not necessary to be reviewed or approved by the UNF IRB. Baptist Medical Center 
IRB reviewed and approved the project via expedited review process. A retrospective chart 
review was conducted to extract de-identified patient descriptive and outcome variables among 
patient’s categorized as prehypertensive by an employee in the primary care practice. The risk to 
patients was considered to be minimal and individual patient informed consent was not required. 
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Chapter Four: Results 
 This chapter reports results that answer the quality improvement project question:  Does 
an educational lifestyle modification program implemented in a primary care setting lower blood 
pressure among adults with preHTN? Data was collected from established patients in the primary 
care setting between February 1, 2013 and June 30, 2013. Results describe the sample, the 
intervention, and report the project outcomes.  
Project Sample 
The quality improvement project was conducted at a rural primary care clinic affiliated 
with a large network of clinics and hospital network. There were five participants in total. The 
participants mean age was 36.4 years (SD=6.9 years), with a range from 26 years to 43 years. 
Three (60%) of the five patients were female. The patients had a mean height of 67.6 inches 
(SD=3.4 inches), with a range from 64 inches to 72 inches. At the beginning of the study the 
mean weight was 204.6 pounds (SD=56.6 pounds), with a range from 158 pounds to 299 pounds. 
Their BMI decreased from baseline to end of study on average by .87 (SD=1.0), with a range 
from -1 (increase) to 2 (decrease). With respect to their heart rate the mean rate was 81 
(SD=12.7), with a range from a heart rate of 63 to 96 beats per minute. The demographic 
information related to the patients is listed in Table 5. In this case, each baseline reading is 
matched with the reading at 3 months (end of study). For each patient, the difference between 
baseline and 3 months was calculated using descriptive analysis to determine change in blood 
pressure readings pre and post program.  
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Intervention and Follow-Up 
 On initial visit all identified prehypertensive adult patients were counseled by the PI 
about LMs, they viewed an educational video that gave a basic description of hypertension, and 
received a PI developed brochure. During the interactive time with the patient, the PI discussed 
lifestyle modification interventions such as weight loss, DASH diet, physical activity, dietary 
sodium reduction and reduction in alcohol consumption with each patient. All patients were 
instructed to return for monthly follow-up visits for 3 months. Each visit included BP, height and 
weight, heart rate and BMI checks. 
Table 5  
 
Description of Patient Characteristics 
   
 
   N Minimum Maximum Mean Std. 
Deviation 
Median 
Age 5 26 43 36.40 6.914 39.00 
BMI change from 
Baseline to End 
5 -1 2 .87 .951 1.10 
BMI Baseline 5 26.30 40.50 31.0600 5.55050 29.90 
BMI End of study 5 27.00 39.15 30.1900 5.11669 28.10 
Heart rate change from 
Baseline to End of study 
5 -3 20 5.00 9.434 2.00 
Heart Rate Baseline 5 63 96 81.00 12.728 86.00 
Heart Rate End of study 5 66 88 76.00 8.124 76.00 
Weight change from 
Baseline to End of study 
5 -3 10 3.80 4.764 5.00 
Weight Baseline 5 158 299 204.60 56.602 178.00 
Weight End of study 5 161 297 200.80 57.081 173.00 
Height (Inches) 5 64 72 67.60 3.362 67.00 
Valid N  5      
 
 28 
Outcomes 
The study began with SBP baseline median of 129 mmHg, with a range from 126 mmHg 
to 137 mmHg. The DBP baseline had a median of 86 mmHg, and a range of 82 mmHg to 90 
mmHg. At the end of the study all five patients had a decrease in SBP and DBP, respectively. 
After participants incorporated one or more LMs, the median SBP decreased to 121 mmHg, and 
ranged from 108 mmHg to 128 mmHg. The end of study median DBP was decreased to 78 
mmHg, and ranged from 77 mmHg to 83 mmHg. The outcome BP from baseline to end of study 
for SBP and DBP is presented in Table 6 and Figure 1. Patients who engaged in LMs had a 
clinically significant decrease in BP.  
Table 6  
 
Outcome Blood Pressure 
 
 
 N Minimum Maximum Mean Std. 
Deviation 
Median 
SBP change from Baseline to 
End 
5 3 18 9.80 5.450 9 
DPB change from Baseline to 
End 
5 3 9 6.40 2.408 7 
SBP Baseline 5 126 137 130.00 4.183 129 
DBP Baseline 5 82 90 85.40 3.130 86 
SBP End of study 5 108 128 120.20 7.662 121 
DBP End of study 5 77 83 79.00 2.550 78 
Valid N 5      
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Figure1. Blood pressure: Systolic Pressure and Diastolic Pressure 
 
Summary 
 The results of this quality improvement project indicate that implementing lifestyle 
modification and blood pressure monitoring in primary care is feasible. All patients received a 
minimum of one LM education intervention through initial contact. Findings indicate that blood 
pressure among this small sample was lowered at the end of the three month monitoring period. 
Statistical significance cannot be inferred due to small sample size; however, lower blood 
pressure would be significant for the individuals.  
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Chapter Five:  Discussion 
This chapter provides a discussion of the major findings of this quality improvement 
lifestyle modification project. The following will be discussed: the major findings and a 
comparison to the findings of similar studies, the clinical relevance to nursing practice, the 
study’s limitations, and suggestions for future research.  
Major Findings 
An educational lifestyle modification program implemented in a primary care setting can 
lower blood pressure among adults with preHTN. The results are consistent with first line 
therapy found in current clinical practice guidelines for adults with prehypertension (USDHHS, 
2004). Lifestyle modification is an important part of treating preHTN and preventing progression 
to HTN. This finding is consistent with the two systematic reviews findings of Ebrahim and 
Smith (1998) and Fleming and Godwin (2008). Incorporating one or more interventions of 
lifestyle modification can reduce adult prehypertension. In the Svetkey et al. (2009) study, the 
physicians received training on JNC7 (USDHHS, 2004) guidelines, LM for BP control, 
treatment algorithms, a decision tree on a pocket sized card, and quarterly feedback reports. The 
patient intervention consisted of 20 weekly group sessions over six months on LMs. The 
combination of physician and patient intervention yielded a total decrease of 9.7 mmHg ± 12.7 
mmHg in systolic blood pressure. 
Clinical Relevance 
As a chronic disease, hypertension is one of the most prevalent conditions in the United 
States. It is responsible for $76.6 billion in health care costs, medications, missed days from 
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work not to mention a risk factor for stroke, heart and kidney disease (Johnson et al., 2011). 
There were many risk factors for preHTN observed in some patients including weight, high 
cholesterol, diabetes and other diseases. The justification for concern of cardiovascular disease is 
more likely to influence clinical practice. To implement this practice change into the clinical 
setting is not only feasible for all providers to accomplish but recommended. Lowering one’s 
blood pressure can also reduce cholesterol levels and blood glucose. Aldana et al. (2005) states 
improvements in nutrition and physical activity, LMs that also lower BP, improves whole body 
glucose tolerance, increases insulin sensitivity, and amount of glucose transporter.  
Lifetime risk of HTN increases as the general population ages. This study examined the 
effectiveness of incorporating a practice change as delineated by the JNC7 (USDHHS, 2004) 
regarding blood pressure. Implementing LMs in the clinical setting can be a challenge. Not all 
patients are receptive to changing behaviors. Therefore, the approach and presentation is crucial. 
Educating patients of diseases that HTN is associated with (heart –LV hypertrophy, angina, heart 
failure; brain – stroke or transient ischemic attack; chronic kidney disease; peripheral arterial 
disease; retinopathy), and that modifiable LMs play a vital role in lowering BP, is therapeutic 
and follows along with current JNC7 (USDHHS, 2004) guidelines. 
Once prehypertenive patients are identified, it takes a few extra minutes to discuss the 
progression to HTN, the diseases HTN is associated with, showing the short video, and/or 
providing educational materials and answering questions to help guide patients on implementing 
the different LMs that can decrease blood pressure. At the end of data collection all participants 
had a lower BP reading compared to the baseline BP. The lower BP suggest that the participants 
followed some or all of the recommended LM practices such as diet rich in whole grains, fruits 
and vegetables, and low-fat diary products (DASH diet) (can reduce BP by 8-14 mmHg), eating 
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less sodium (can reduce BP by 2-8 mmHg), limiting alcoholic beverages can reduce BP by 2-4 
mmHg), engaging in exercise (can reduce BP by 4-9 mmHg), losing weight (can reduce BP by 5-
20 mmHg/kg), and smoking cessation (can reduce overall risk for cardiovascular disease) 
(USDHHS 2004). 
The JNC7 (USDHHS, 2004), calls for providers to begin prompt implementation of LMs 
for adults with preHTN to stop the progression to HTN. Because of the known effectiveness of 
LMs modifications, Guo et al. (2011) suggests providers also be aware of individuals at an 
increased risk for cardiovascular disease. Once identified, providers should encourage patients to 
incorporate as many LMs to reduce modifiable risk factors for a greater benefit. From a clinical 
perspective it is crucial that providers begin this intervention as the standard of care.  
As early as two months ago the USDHHS released the Eighth Joint National Committee 
(JNC 8) recommending nine new guidelines on the management of adult hypertension. The 
greatest change is in patient’s aged ≥60 years to initiate pharmacologic treatment at SBP ≥ 150 
mmHg or DBP ≥90 mmHg to a goal of SBP ≤150 mmHg and DBP ≤90 mmHg. The new JNC 8 
has not changed the parameters for the new PreHTN classification and LM remains the 
recommended treatment so the results of this project are not affected by the update of the 
guidelines. Providers should be aware that guidelines change and are revised and updated 
periodically as new evidence emerges. 
Limitations 
This quality improvement project targeted adults with preHTN in a rural setting. The 
main limitation to this project was the limited number of patients with prehypertension. In many 
cases, patients were either already diagnosed with HTN or were already being treated with 
medication therapy. Therefore sample size became the major limitation to this study. Secondly, 
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due to administrative security settings on the computers, in the office, a personal electronic 
device had to be used to show the short video on basic HTN. Had access to the Internet been 
possible on clinic computers, the process would have been shorter and the provider could have 
spent more time with the patient on the educational program. Third, even though the clinical 
setting allowed participants to schedule follow-up BP readings freely and at their convenience, 
there were participants lost to follow up. The main reason stated for this was time off from work. 
Many participants were unable or unwilling to take the time off from work during clinic hours. 
Offering extended hours for a specific day of the month for return visits could have provided for 
a lower loss to follow up rate. Also, individuals may have returned for clinic visits if they 
received reminders. 
Implication for Future Study 
Future study should include identifying strategies to increase patient participation and 
improve sample size. This can be achieved by increasing patient awareness of guidelines, 
consequences of HTN, and benefits of incorporating one or more lifestyle modifications into 
their daily lives. Finally, more study is needed and would be beneficial if long-term benefits of 
LMs that reduce disease morbidity and mortality are studied.  
Conclusion 
This study suggests that an educational lifestyle modification program implemented in a 
primary care setting is feasible and can have a positive effect on lowering blood pressure among 
adults with preHTN. Providers can confidently promote LMs to reduce BP using JNC7 
(USDHHS, 2004) guidelines and available educational materials and resources. Whittmore et al. 
(2010) reports that the implementation becomes easier over time. The significance to patients 
includes positive health outcomes and reduced reliance on pharmaceutical measures to control 
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HTN. Consequently, patients with their providers can impact healthcare costs, prevent the 
progression of preHTN to HTN, and reduce stroke, heart, kidney, and other diseases. 
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Appendix A 
Lifestyle Modification (LM) Intervention 
Intervention and First Line Treatment of Prehypertension in Primary Care 
 
 During an office visit the primary care provider addresses blood pressure with the patient 
using the 5 A’s Behavior Change Model (Assess, Advise, Agree, Assist and Arrange) as a guide.  
 
Ask and Assess about lifestyle behaviors: 
 
NP might say 
“Good morning/afternoon, in looking at your vital signs, I notice your blood pressure is slightly 
elevated”. “Can we talk about that for a minute?”[Asking permission] 
“Did you know that what was once considered normal BP, 120’s/80’s, is now considered 
prehypertension by the new JNC 7 guidelines?” “Although your blood pressure is not classified 
as high blood pressure, it could progress to it”  
“The new guidelines now want providers to intervene at this time to prevent the progression to 
hypertension.” This is done with what is called Lifestyle modifications; do you know what those 
are?”  
[Assessing basic knowledge of HTN and assessing lifestyle] 
 
Information provided includes: Explain prehypertension to patient. Show short 1:32 second 
educational video about the basics of HTN. The video is completely on the layperson’s level of 
understanding. It demonstrates blood flow, factors affecting it, and the dangers resulting from 
HTN. 
 
After the video is shown the NP then uses motivational interviewing techniques to advise the 
patient about changing the behaviors that are applicable. Ask permission to talk about LM, this 
shows respect and caring for patient. 
“What is your daily diet like?” “Do you exercise regularly?”  
If they smoke, are overweight, and/or drink alcohol the NP might say: 
“I see that you are a daily smoker, how much do you smoke?” “Any thoughts on quitting?” 
“What kind of alcohol do you drink and how much?” “Any thoughts on quitting or limiting 
intake?” 
 
Advise and Agree to change LM: Motivational interviewing: 
 
NP might say 
“Would you be interested in learning how you can reduce your blood pressure?” 
“Let’s talk about changing your daily diet and incorporating an exercise regimen?”  
 “Did you know that cutting your sodium intake down to 2400 grams a day, 1 teaspoon, can 
reduce you BP by approximately 2-8 points”, and that brisk walking 30 minutes a day for most 
days of the week reduces your BP by 4-9 points?” 
 
Information provided includes: Patients that are interested in reducing BP the NP might say, “I 
am glad you recognize the potential benefits of lifestyle changes.” A LM brochure is then handed 
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and reviewed with the patient. This leads to in depth counseling on benefits of LM, harms of 
HTN, and short and long-term goal setting.  
 
For the prehypertenive patient unsure of using LM to reduce BP the NP might say “what 
concerns you most about reducing your BP?” This might introduce barriers and challenges that 
need to be addressed and overcome. The patient may not perceive a need to change if they are 
not experiencing any apparent problems at this time. Giving this patient brief advice on BP 
reduction may lead to future interest in LM changes when those challenges and barriers are 
reduced or removed. The NP might say, “Perhaps we can address this again at your next visit.” 
 
Assist and Arrange LM incorporation: The patient who desires to make LM changes and set a 
goal date. 
 
Information provided includes: The NP provides counseling based on the JNC7 (USDHHS, 
2004) and on individual assessments of patient’s lifestyle. The NP helps the patient devise a Self-
Management Action Plan. The plan addresses barriers and concerns, and strategies that will 
encourage and increase the chance of successful LM incorporation. A handout on the Dietary 
Approach to Stop Hypertension (DASH) diet is given to assist the patient in knowing the proper 
foods to eat. The LM brochure also has links to websites the patient can access at their own 
convenience to aid in their knowledge and success of these changes. 
 
Arrange for follow-up: 
 
Information provided includes: At monthly intervals the patient will visit the office for routine 
height and weight, and BP measurements. The patient may also call the office or schedule an 
appointment with the NP for any questions or concerns. 
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MEMORANDUM 
 
 
TO:  Andrea M. Patterson, MSN, FNP-BC 
FROM: Michael Joyce, MD, PhD 
 
DATE:  November 11, 2013 
 
RE:  Expedited Review – Initial Approval                                           
 
 
  
The Institutional Review Board (IRB) of Baptist Medical Center (BMC) met on October 
17, 2013 and the following new protocol was reviewed and approved via expedited 
review for a period of one year: 
 
#13-66, Baptist, "Evaluating The Effects of an Educational Lifestyle 
Modification Intervention on Blood Pressure in Adults with Hypertension" 
-Introductory Questionnaire; Protocol Submission Checklist; Protocol Version 1 
dated 12 July 2013; HIPAA Waiver; UNF IRB Waiver dated 11 October 2013 
 
The anniversary date for this study is October 16, 2014.  At that time, please submit a 
report of your experiences with this protocol.  
 
Should you have any questions, please contact the IRB office.  The BMC IRB meets the 
requirements in 21 CFR 56 (Rev.), 45 CFR 46 (Rev.) and ICH (E6) GCP guidelines.  
Good luck with this endeavor. 
 
 
 
 
 
 
 
 
820 Prudential Drive, Suite 413 
Jacksonville, Florida 32207 
Phone: 904.202.2127 
Fax: 904.202.2331 
ircsubmission@bmcjax.com 
  
 
 
Signature 
Deleted
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